Igor Larrañaga
Impact in
-
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 8
- Co-authors
- Javier Mar (22 shared papers)Carmen Navarro (1 shared paper)Nieves Ascunce (1 shared paper)Luis C. González (1 shared paper)Oliver Ibarrondo (16 shared papers)Sílvia de Sanjosé (1 shared paper)Pilar Moreo (1 shared paper)Núbia Muñóz (1 shared paper)
- Journals
- Journal of Alzheimer s Disease (2 papers)Value in Health (2 papers)GeroScience (1 paper)Journal of Medical Screening (1 paper)PharmacoEconomics (1 paper)
- Partner nations
- SpainItalyUnited States
In The Last Decade
Igor Larrañaga
26 papers receiving 237 citations
Peers
Comparison fields: 5 of 75
- Epidemiology 107
- Health Informatics 4
- Geriatrics and Gerontology 11
- Microbiology 16
- Health 20
Countries citing papers authored by Igor Larrañaga
This map shows the geographic impact of Igor Larrañaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Larrañaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Larrañaga more than expected).
Fields of papers citing papers by Igor Larrañaga
This network shows the impact of papers produced by Igor Larrañaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Larrañaga. The network helps show where Igor Larrañaga may publish in the future.
Co-authors
The 25 scholars most cited alongside Igor Larrañaga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia. | 1993 | 100 |
| 2 | 2020 | 19 | |
| 3 | 2021 | 12 | |
| 4 | 2018 | 12 | |
| 5 | 2016 | 11 | |
| 6 | 2022 | 10 | |
| 7 | 2021 | 9 | |
| 8 | 2017 | 9 | |
| 9 | 2019 | 8 | |
| 10 | 2023 | 7 | |
| 11 | 2020 | 6 | |
| 12 | 2022 | 5 | |
| 13 | 2021 | 4 | |
| 14 | 2021 | 3 | |
| 15 | 2017 | 3 | |
| 16 | 2016 | 3 | |
| 17 | 2018 | 3 | |
| 18 | 2023 | 2 | |
| 19 | 2024 | 2 | |
| 20 | 2023 | 2 |
About Igor Larrañaga
Igor Larrañaga is a scholar working on General Health Professions, Economics and Econometrics, Health, Psychiatry and Mental health and Epidemiology, having authored 27 papers that have together received 240 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Dementia and Cognitive Impairment Research (5 papers), Health disparities and outcomes (4 papers), Mental Health Treatment and Access (3 papers), Chronic Disease Management Strategies (3 papers), Pain Management and Opioid Use (2 papers), Vaccine Coverage and Hesitancy (2 papers) and Insurance, Mortality, Demography, Risk Management (2 papers). The work is most often cited by research in Epidemiology (107 citations), Health Informatics (4 citations), Geriatrics and Gerontology (11 citations), Microbiology (16 citations) and Health (20 citations). Igor Larrañaga has collaborated with scholars based in Spain, Italy and United States. Frequent co-authors include Javier Mar, Carmen Navarro, Nieves Ascunce, Luis C. González, Oliver Ibarrondo, Sílvia de Sanjosé, Pilar Moreo, Núbia Muñóz, F. Xavier Bosch and L Tafur. Their work appears in journals such as Journal of Alzheimer s Disease, Value in Health, GeroScience, Journal of Medical Screening and PharmacoEconomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.